A Unique Plasma Protein Signature Characterizes Squamous Cell Carcinoma of the Oral Tongue in Young Adults
Journal of Oral Pathology & Medicine, 2025
Gu X., Coates P., Wang L., Gnanasundram S., Sgaramella N., Attaran N., Erdogan B., Magan M., Nylander K.
| Disease area | Application area | Sample type | Products |
|---|---|---|---|
Oncology | Pathophysiology Patient Stratification | Plasma |  Olink Explore 3072/384 |
Abstract
Background
The incidence of squamous cell carcinoma of the oral tongue (SCCOT) among young adults is increasing in several regions of the world. Age‐dependent differences in the biology of SCCOT have been suspected.
Methods
We used the Olink Explore 3072 high‐throughput platform to comprehensively quantify plasma proteins in 24 young (≤ 40 years of age) and 50 old (> 50 years of age) individuals. Eight young and 20 old individuals were diagnosed with SCCOT, four young and nine old individuals with SCC at other oral subsites (SCCOO), and the remaining 12 young and 21 old individuals were healthy controls. Dimension reduction analysis, differential expression analysis, and functional enrichment analysis were performed to characterize young patient‐specific biological signatures.
Results
Plasma levels of 2923 proteins were obtained. Principal component analysis indicated age‐related expression patterns. Comparing young patients to young controls/old patients/old controls, differential abundance analysis showed that increases in protein levels of Peroxiredoxin 2 (PRDX2) and C‐C motif chemokine ligand 26 (CCL26) and a decrease in Kallikrein related peptidase 4 (KLK4) were young patient‐specific. Reactome pathway enrichment analysis identified “Cellular response to chemical stress,” “Detoxification of reactive oxygen species” and “Cellular responses to stimuli” as the top altered pathways in young patients with SCCOT.
Conclusions
Abnormal cellular stress and aberrant immune regulation could thus be linked to cancer development in young patients. The unique plasma proteomic signature observed in young patients with SCCOT suggests that they constitute a specific group with distinct underlying pathophysiological processes.